An increase in intracellular content of oligomeric Aβs is believed to play a major role in the early phase of AD as their intracellular rise strongly correlates with AD symptoms, and has been proven to be predictive of cognitive status in AD-affected patients [4,5,6]. Here, DDX41 is linked to Alzheimer disease.